Details of the Drug Reposition

General Information of This Drug (ID: DM5BL4C)

Drug Name
Veltuzumab   DM5BL4C
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Solid tumour/cancer DISZR48F 2A00-2F9Z Phase 2 [1]
Chronic lymphocytic leukaemia DISEXWC3 2A82.0 Phase 2 [2]
Non-hodgkin lymphoma DISS2Y8A 2B33.5 Phase 2 [2]
Systemic lupus erythematosus DISI1SZ7 4A40.0 Phase 2 [2]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Thrombocytopenia DISU61YW 3B64 Phase 1/2 [3]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8268).
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)